Male birth control shot moves closer to reality
NCT ID NCT02927210
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single injection of a potential male contraceptive called DMAU in 106 healthy men. The goal was to check its safety and how the body processes it. Researchers gave different doses either into muscle or under the skin to find the best approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, 90509, United States
-
University of Washington Medical Center & Health Sciences
Seattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Male birth control pill enters human testing
- Hormone gel transfer: does washing or clothing protect women?
- New male birth control pill could work in minutes
- Male birth control pill moves closer to reality
- Hydrogel implant could offer reversible male contraception
- New male pill aims to stop sperm production